We also observed, as previously reported, that modulation of PD-L1, by silencing or with PD-L1 monoclonal antibodies, significantly induced CTLs mediated killing of ccRCC cells, A498 and 786-O. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.